Melanoma: The Newest Immunotherapies and Target Drug Options
Melanoma accounts for less than two percent of all skin cancers but it is the cause of most skin cancer deaths. Just over 10,000 patients a year die from the disease. These sober statistics sparked a focus on new treatments to decrease mortality rates, such as BRAF and MEK inhibitors. The FDA has approved two…